The Impact Of Allogeneic Hematopoietic Cell Transplantation (Allohct) On The Outcome Of Poor-Risk Non-Hodgkin Lymphoma (Nhl): A Retrospective Intent-To-Transplant (Itt) Analysis

Although alloHCT is an accepted salvage treatment in defined settings of poor-risk NHL, its potential benefit in these indications remains controversial because virtually all published studies are uncontrolled and restricted to patients who were actually able to undergo transplantation. Here, we aimed at assessing the impact of alloHCT by measuring its outcome from the time of donor search indication rather than from the time of transplant, thereby taking into account those patients who fail to proceed to allografting for any reason.